Cocrystal Pharma (COCP) Cash from Investing Activities (2010 - 2024)
Cocrystal Pharma (COCP) reported Cash from Investing Activities of -$8000.0 for Q1 2024, up 82.22% on a YoY basis from -$4390.2 in Q2 2023, and up 86.44% sequentially from -$59000.0 in Q4 2023.
Cocrystal Pharma (COCP) Cash from Investing Activities (2010 - 2024) Analysis & Trends
Cocrystal Pharma (COCP) has 14 years of Cash from Investing Activities data on file, last reported at -$8000.0 in Q1 2024.
- For the quarter ending Q1 2024, Cash from Investing Activities rose 82.22% year-over-year to -$8000.0; the trailing twelve-month figure through Dec 2024 stood at -$8000.0 (up 93.22% YoY), and the FY2025 full-year result was -$12000.0, down 50.0% from the prior year.
- Cash from Investing Activities grew to -$8000.0 in Q1 2024, from -$59000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1000.0 in Q4 2020 to a low of -$127000.0 in Q2 2020.
- A 5-year average of -$33076.9 and a median of -$15000.0 in 2021 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities sank 3075.0% in 2020 and surged 88.19% in 2021, its largest moves.
- Tracing COCP's Cash from Investing Activities over 5 years: stood at -$1000.0 in 2020, then plunged by 700.0% to -$8000.0 in 2021, then tumbled by 50.0% to -$12000.0 in 2022, then sank by 391.67% to -$59000.0 in 2023, then surged by 86.44% to -$8000.0 in 2024.
- Business Quant data shows COCP's Cash from Investing Activities at -$8000.0 in Q1 2024, -$59000.0 in Q4 2023, and -$14000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Mar 31, 2023 | -45,000.00 |
| Mar 31, 2023 | -45,000.00 |
| Dec 31, 2022 | -12,000.00 |
| Dec 31, 2022 | -12,000.00 |
| Dec 31, 2021 | -8,000.00 |
| Dec 31, 2021 | -8,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -15,000.00 |
| Jun 30, 2021 | -15,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |